Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisHuilin Xu, Wei Ge, Dingjie Zhou et al.|Annals of Translational Medicine|2023Cited by 0